The eagle flies on Friday

Friday proved fruitful for the biotech market, allowing three companies to raise an aggregate $72 million in public money. Closers include Ligand (LGND), which raised $33 million through the sale of 2.75 million shares at $12. Sugen (SUGN) banked $24 million, pricing 2 million shares at $12; while Cubist (CBST) raised $15 million in a deeply discounted IPO (see below).

NEW TO MARKET: CBST sold 2.5 million shares at $6, half of what the infectious disease company had hoped to

Read the full 793 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE